SCHEMBL822882

SCHEMBL822882

Cc1cc(-c2ccc(Cl)cc2)cc(C)c1C1=C(OC(=O)C(C)C)C(C)NC1=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ACACB O00763 3/20 0.32
ACACA Q13085 3/20 0.32
ALPL P05186 1/20 0.32
KDM4E B2RXH2 2/20 0.32
HPGD P15428 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
TP53 P04637 1/20 0.31
MDM2 Q00987 1/20 0.31
LTB4R Q15722 1/20 0.31
PPARD Q03181 1/20 0.31
PTGER4 P35408 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
FPR1 P21462 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL811947 0.77 RAB9A (0.33) LMNAMAPTALDH1A1TDP1TP53
SCHEMBL812252 0.74 ACACB (0.43) TDP1ACACBACACANPSR1HTT
SCHEMBL812037 0.72 PGR (0.34) LMNAMAPTALDH1A1TDP1ACACB
SCHEMBL14066725 0.70 MAPT (0.32) LMNAMAPTALDH1A1TDP1ACACB
SCHEMBL4546199 0.69 ACACB (0.39) LMNAMAPTALDH1A1TDP1ACACB
SCHEMBL811909 0.67 ACACB (0.38) LMNAMAPTALDH1A1ACACBACACA
SCHEMBL823017 0.63 KMT2A (0.34) LMNAALDH1A1PPARDKMT2ASMN1; SMN2
SCHEMBL18873885 0.63 L3MBTL1 (0.33) LMNAMAPTALDH1A1KDM4EHPGD
SCHEMBL812286 0.63 LMNA (0.39) LMNAMAPTALDH1A1TDP1ALPL
SCHEMBL812168 0.62 ACACB (0.40) LMNAMAPTALDH1A1TDP1ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058210-B2 Arylphenyl-substituted cyclic keto-enols BAYER CROPSCIENCE AG (DE) 2011-11-15 US disclosed
US-7718706-B2 Arylphenyl-substituted cyclic keto-enols BAYER AKTIENGESELLSCHAFT (DE) 2010-05-18 US disclosed
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS LIEB FOLKER 2010-04-08 US disclosed
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols LIEB FOLKER 2008-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols KCNE1, DDT, KCNQ3 LMNA 2176/4885MAPT 4775/4885ALDH1A1 2569/4885
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS KCNE1, DDT, KCNQ3 LMNA 2176/4885MAPT 4775/4885ALDH1A1 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.